InterCure Ltd. (TLV:INCR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
301.30
-6.40 (-2.08%)
Jan 14, 2026, 2:15 PM IDT
-50.76%
Market Cap168.25M
Revenue (ttm)243.12M
Net Income (ttm)-70.93M
Shares Out54.68M
EPS (ttm)-1.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume31,997
Average Volume186,784
Open307.70
Previous Close307.70
Day's Range301.00 - 308.50
52-Week Range297.00 - 644.90
Beta0.53
RSI28.26
Earnings DateMar 30, 2026

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 ... [Read more]

Sector Healthcare
Founded 1994
Employees 320
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol INCR
Full Company Profile

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.

Financial Statements

News

There is no news available yet.